Globus Medical (GMED) Change in Receivables (2011 - 2026)

Globus Medical has reported Change in Receivables for 16 years, with the latest figure at $13.4 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Receivables rose 159.28% year-over-year to $13.4 million; the trailing twelve-month figure through Mar 2026 stood at $88.2 million (up 362.52% YoY), and the FY2025 full-year result was $52.2 million, down 33.15% from the prior year.
• Change in Receivables for Q1 2026 stood at $13.4 million, down from $64.2 million in the prior quarter.
• The five-year high for Change in Receivables was $87.8 million in Q2 2024, with the low at -$23.7 million in Q3 2024.
• Historically, Change in Receivables has averaged $14.4 million across 5 years, with a median of $9.9 million in 2023.
• Annual changes were most pronounced in 2023 — Change in Receivables soared 510.97% — and 2024, when it slumped 371.47%.
• Globus Medical's Change in Receivables stood at $4.6 million in 2022, then jumped by 179.15% to $13.0 million in 2023, then plunged by 273.47% to -$22.5 million in 2024, then surged by 385.34% to $64.2 million in 2025, then slumped by 79.11% to $13.4 million in 2026.
• The last three Change in Receivables figures came in at $13.4 million (Q1 2026), $64.2 million (Q4 2025), and $8.4 million (Q3 2025), per Business Quant data.